BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial

SAMMAMISH, Wash. — BaroPace Inc., a medical device company focused on the development of PressurePace™, a real-time physiologic control software and hardware to regulate cardiac pacemakers to treat resistant hypertension and heart failure with preserved ejection fraction (HFpEF), today announced that the first patient has been enrolled in the Company’sContinue Reading

Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa

Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new strategic partnership and exclusive licensing agreement with SK Biopharmaceuticals, a global biotech company focused on the development of treatments for central nervous system (CNS) disorders and oncology, for the Middle East and North Africa (MENA). UnderContinue Reading

درة زروق تنضم إلى “فاتيكا” لتصبح واجهةً للحملة الجديدة “الزيت قبل الشامبو”:

nited Arab Emirates, August 2nd, 2023: Vatika, the leading Natural hair care brand in the middle east region has signed up the acclaimed Arab actress Dorra Zarrouk as the face of their new “Oil before shampoo” campaign. The campaign exemplifies the importance of hair oiling prior to every hair washContinue Reading

The UAE’s 1st CARF Accredited Autism Program at Ability Pediatric Rehabilitation Medical Center (Abu Dhabi)

Abu Dhabi, United Arab Emirates — Ability Pediatric Rehabilitation Medical Center (APRMC) in Abu Dhabi has become the first Center in the UAE to be awarded the CARF Accreditation for their early intervention, child, and youth services which provide specialized support to children and adolescents with autism spectrum disorder (ASD).Continue Reading

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and commercialisation agreement with Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercialising precision, cell targeting therapies based on its proprietary Alluminox™ platform. Under the terms of the agreement, Hikma hasContinue Reading

Now Health International celebrates another service success

Award-winning International Private Medical Insurance (IPMI) provider Now Health International is celebrating its latest customer service success, having won another prestigious award, Customer Service Initiative of the Year, recognising its leadership in this area. In addition to its TrustPilot score reflecting how the company’s members feel about its products andContinue Reading

‘Where there is Clove, there is no cavity.’

Dabur Herb’l launches a new campaign highlighting the importance of Clove in tooth cavity protection Dabur Herb’l Clove, known for its potent cavity-fighting formula, has launched a new campaign to reinforce the remarkable benefits of its Clove-infused toothpaste. Titled “Where there is Clove, there is no Cavity,” the campaign emphasizesContinue Reading

سن كيس تطلق أول واقي شمسي معطر في العالم مصمم خصيصاً للعلامات التجارية الفندقية في دولة الإمارات

SunKiss, the UAE homegrown developer of sustainable and environmentally friendly suncare products, has launched the world’s first bespoke sun protection scent, providing hospitality brands with the opportunity to develop a unique fragrance for their property or hospitality group. The company, which has added this new line following a period ofContinue Reading

BaroPace Receives Approval for First-in-Human Clinical Trial

SAMMAMISH, Wash. — BaroPace, Inc., a medical technology company dedicated to using blood pressure to regulate pacemakers for patients with heart failure with preserved ejection fraction and hypertension, announced today that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) of India to conduct its clinical trialContinue Reading